My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

223.32 -0.66 (-0.29%)

Official Closing Price Updated: 7:00 PM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

90 91 Next >

My Top 3 Healthcare Stocks to Buy in 2026 ↗

December 13, 2025

These habitual market beaters can pull it off again.

Via The Motley Fool

Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 ↗

December 12, 2025

They could grow into their valuation over the next few years.

Via The Motley Fool

Topics Intellectual Property

Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul ↗

December 12, 2025

Via MarketBeat

The Smartest Dividend Stocks to Buy With $5,000 Right Now ↗

December 12, 2025

See what solid dividends do for a portfolio after just five years.

Via The Motley Fool

Topics Retirement

2 Mega-Cap Stocks with Exciting Potential and 1 We Ignore

December 11, 2025

Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing...

Via StockStory

Is AbbVie Stock Too Cheap to Ignore at Today's Price? ↗

December 11, 2025

The drugmaker has plenty to offer investors.

Via The Motley Fool

Topics Intellectual Property

Guardian Wealth Doubles Down on LKQ Stock With $1.8 Million Purchase, According to Recent SEC Filing ↗

December 10, 2025

Guardian Wealth Management raised its stake in LKQ stock to nearly $4.9 Million during the third quarter of 2025.

Via The Motley Fool

Topics Regulatory Compliance

Guardian Wealth Takes $5.1 Million Stake in Viper Energy, According to Recent SEC Filing ↗

December 10, 2025

Guardian Wealth bought over 133,000 shares of Viper Energy during the third quarter of 2025.

Via The Motley Fool

Topics Energy Regulatory Compliance

Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution

December 09, 2025

New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index...

Via MarketMinute

Topics ETFs Economy Intellectual Property

1 Major Factor Behind the Healthcare Sector's Recent Surge ↗

December 09, 2025

Blockbuster drugs are a major driver of the growth of healthcare stocks.

Via The Motley Fool

3 Top Dividend Stocks to Buy in December ↗

December 09, 2025

Great dividends are only part of the attraction with these stocks.

Via The Motley Fool

Topics Initial Public Offering Intellectual Property

The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. ↗

December 06, 2025

This drugmaker has a strong portfolio of best-selling drugs and a growing pipeline.

Via The Motley Fool

Topics ETFs

Could Buying AbbVie Today Set You Up for Life? ↗

December 04, 2025

Don't bet against it.

Via The Motley Fool

Topics Intellectual Property Lawsuit

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗

December 04, 2025

These ETFs can provide me with lots of passive income.

Via The Motley Fool

Topics ETFs Stocks

Morgan Stanley Downgrades Regeneron (REGN) to Equal-Weight, Citing Fair Valuation and Pipeline Scrutiny

December 03, 2025

New York, NY – December 3, 2025 – In a significant move reverberating through the biotechnology sector, investment banking giant Morgan Stanley has downgraded Regeneron Pharmaceuticals (NASDAQ: REGN)...

Via MarketMinute

Topics Intellectual Property

2 Top Dividend Stocks to Buy Now and Hold For a Decade ↗

December 02, 2025

These healthcare leaders can make you money while you sleep.

Via The Motley Fool

Topics Artificial Intelligence Cannabis Intellectual Property

3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years ↗

November 29, 2025

These stocks have been raising their dividend payments annually for well over a decade, and they pay more than twice the S&P 500 average.

Via The Motley Fool

Topics Stocks

8 Dividend Stocks Every Investor Should Consider ↗

November 28, 2025

From high-yield pharma plays to growth-oriented compounders, these eight stocks offer something for every dividend investor.

Via The Motley Fool

Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗

November 27, 2025

Pricing updates for major therapies from Novo Nordisk, Teva, AbbVie, and others eased sector worries.

Via Stocktwits

Topics ETFs

Exploring the top movers within the S&P500 index during today's session. ↗

November 26, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

1 Surging Stock with Exciting Potential and 2 Facing Challenges

November 25, 2025

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

Via StockStory

Topics Bankruptcy

5 Dividend Stocks to Hold for the Next 10 Years ↗

November 24, 2025

Investors should be able to count on steady dividends from these great stocks.

Via The Motley Fool

Topics Energy Retirement

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy Government World Trade

Unpacking the Latest Options Trading Trends in AbbVie ↗

November 20, 2025

Via Benzinga

If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today ↗

November 19, 2025

Via Benzinga

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗

November 19, 2025

Via MarketBeat

Healthcare Rotation Underway: 3 Stocks Leading the Charge ↗

November 19, 2025

Via MarketBeat

3 Cash-Producing Stocks We Think Twice About

November 19, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Topics Derivatives

A Look Into AbbVie Inc's Price Over Earnings ↗

November 17, 2025

Via Benzinga

AbbVie Stock Falls 4% -- What Investors Need to Know ↗

November 17, 2025

It's no reason to stay up at night.

Via The Motley Fool

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

90 91 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.